Melanocortin-1 receptor (MC1R) genotypes do not correlate with size in two cohorts of medium-to-giant congenital melanocytic nevi

Congenital melanocytic nevi (CMN) are cutaneous malformations whose prevalence is inversely correlated with projected adult size. CMN are caused by somatic mutations, but epidemiological studies suggest that germline genetic factors may influence CMN development. In CMN patients from the U.K., genetic variants in the MC1R gene, such as p.V92M and loss-of-function variants, have been previously associated with larger CMN. We analyzed the association of MC1R variants with CMN characteristics in 113 medium-to-giant CMN patients from Spain and from a distinct cohort of 53 patients from France, Norway, Canada and the U.S. These cohorts were similar at the clinical and phenotypical level, except for the number of nevi per patient. We found that the p.V92M or loss-of-function MC1R variants either alone or in combination did not correlate with CMN size, in contrast to the U.K. CMN patients. An additional case-control analysis with 259 unaffected Spanish individuals, showed a higher frequency of MC1R compound heterozygous or homozygous variant genotypes in Spanish CMN patients compared to the control population (15.9% vs. 9.3%; P=0.075). Altogether, this study suggests that MC1R variants are not associated with CMN size in these non-U.K. cohorts. Additional studies are required to define the potential role of MC1R as a risk factor in CMN development.

[1]  V. Kinsler,et al.  The biker‐glove pattern of congenital melanocytic nevi , 2019, Pediatric dermatology.

[2]  D. Lomas,et al.  Does the gene matter? Genotype–phenotype and genotype–outcome associations in congenital melanocytic naevi[Link] , 2019, The British journal of dermatology.

[3]  F. Tirode,et al.  Malignant melanoma with areas of rhabdomyosarcomatous differentiation arising in a giant congenital nevus with RAF1 gene fusion , 2019, Pigment cell & melanoma research.

[4]  J. Malvehy,et al.  Genetic Abnormalities in Large to Giant Congenital Nevi: Beyond NRAS Mutations. , 2019, The Journal of investigative dermatology.

[5]  K. Rawlik,et al.  Genome-wide study of hair colour in UK Biobank explains most of the SNP heritability , 2018, Nature Communications.

[6]  A. Barkovich,et al.  New insights into neurocutaneous melanosis , 2018, Pediatric Radiology.

[7]  Saint-Just N. Petnga,et al.  Giant congenital melanocytic nevus in a Cameroonian child: a case report , 2018, Journal of Medical Case Reports.

[8]  Jiali Han,et al.  MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project , 2018, Cancer management and research.

[9]  J. Malvehy,et al.  Melanocortin 1 receptor (MC1R) polymorphisms’ influence on size and dermoscopic features of nevi , 2018, Pigment cell & melanoma research.

[10]  J. García-Borrón,et al.  MC1R signaling. Intracellular partners and pathophysiological implications. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[11]  T. Jacques,et al.  Melanoma in congenital melanocytic naevi , 2017, The British journal of dermatology.

[12]  A. Marghoob,et al.  Patterns of distribution of giant congenital melanocytic nevi (GCMN): The 6B rule , 2017, Journal of the American Academy of Dermatology.

[13]  B. Brown,et al.  Giant melanocytic nevus with malignant melanoma: a rare disorder in a black African child , 2014, International journal of dermatology.

[14]  S. Gazal,et al.  A Large French Case-Control Study Emphasizes the Role of Rare Mc1R Variants in Melanoma Risk , 2014, BioMed research international.

[15]  X. Su,et al.  NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi. , 2014, The Journal of investigative dermatology.

[16]  P. Demaerel,et al.  A newborn with neurocutaneous melanocytosis and Dandy-Walker malformation. , 2014, Pediatric neurology.

[17]  J. Malvehy,et al.  Distribution of MC1R variants among melanoma subtypes: p.R163Q is associated with lentigo maligna melanoma in a Mediterranean population , 2013, The British journal of dermatology.

[18]  A. Marghoob,et al.  New recommendations for the categorization of cutaneous features of congenital melanocytic nevi. , 2013, Journal of the American Academy of Dermatology.

[19]  O. Ibrahimi,et al.  Congenital melanocytic nevi: where are we now? Part I. Clinical presentation, epidemiology, pathogenesis, histology, malignant transformation, and neurocutaneous melanosis. , 2012, Journal of the American Academy of Dermatology.

[20]  S. Ring,et al.  Germline Melanocortin-1-Receptor Genotype Is Associated with Severity of Cutaneous Phenotype in Congenital Melanocytic Nevi: A Role for MC1R in Human Fetal Development , 2012, The Journal of investigative dermatology.

[21]  R. Hennekam,et al.  The face in congenital melanocytic nevus syndrome , 2012, American journal of medical genetics. Part A.

[22]  N. Hayward,et al.  Melanocortin 1 receptor and risk of cutaneous melanoma: A meta‐analysis and estimates of population burden , 2011, International journal of cancer.

[23]  A. Stratigos,et al.  Melanocortin 1 Receptor Variants: Functional Role and Pigmentary Associations , 2011, Photochemistry and photobiology.

[24]  V. Kinsler Satellite Lesions in Congenital Melanocytic Nevi—Time for a Change of Name , 2011, Pediatric dermatology.

[25]  R. Hennekam,et al.  Familial clustering of giant congenital melanocytic nevi. , 2010, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[26]  J. Schaffer,et al.  Congenital melanocytic nevi-when to worry and how to treat: Facts and controversies. , 2010, Clinics in dermatology.

[27]  B. Catteau,et al.  Neurocutaneous melanosis and the Dandy–Walker complex: an uncommon but not so insignificant association , 2009, Child's Nervous System.

[28]  M. Koubeissi,et al.  Symptomatic neurocutaneous melanosis and Dandy-Walker malformation in an adult. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  R. Sturm,et al.  Molecular genetics of human pigmentation diversity. , 2009, Human molecular genetics.

[30]  V. Kinsler,et al.  Great Ormond Street Hospital for Children Registry for Congenital Melanocytic Naevi: prospective study 1988–2007. Part 1—epidemiology, phenotype and outcomes , 2009, The British journal of dermatology.

[31]  L. Prantl,et al.  Neurocutaneous melanosis in association with Dandy–Walker malformation: case report and literature review , 2008, Clinical and experimental dermatology.

[32]  F. Sera,et al.  MC1R variants, melanoma and red hair color phenotype: A meta‐analysis , 2008, International journal of cancer.

[33]  J. Benítez,et al.  MC1R: three novel variants identified in a malignant melanoma association study in the Spanish population. , 2007, Carcinogenesis.

[34]  G. Ghanem,et al.  Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic nevi. , 2007, The Journal of investigative dermatology.

[35]  A. Goldstein,et al.  Comprehensive evaluation of allele frequency differences of MC1R variants across populations , 2007 .

[36]  N. Chiu,et al.  Neurocutaneous melanosis with hydrocephalus: report of one case. , 2004, Acta neurologica Taiwanica.

[37]  A. Marghoob,et al.  Number of satellite nevi as a correlate for neurocutaneous melanocytosis in patients with large congenital melanocytic nevi. , 2004, Archives of dermatology.

[38]  R. Happle,et al.  Large congenital melanocytic nevi may reflect paradominant inheritance implying allelic loss. , 2003, European journal of dermatology : EJD.

[39]  R. Foster,et al.  Giant Congenital Melanocytic Nevi: The Significance of Neurocutaneous Melanosis in Neurologically Asymptomatic Children , 2001, Plastic and reconstructive surgery.

[40]  Y. Z. Shen,et al.  Neurocutaneous melanosis with epilepsy: report of one case. , 2001, Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi.

[41]  G. Jansen,et al.  Neurocutaneous melanosis with hydrocephalus, intraspinal arachnoid collections and syringomyelia: case report and literature review , 2000, Pediatric Radiology.

[42]  Ian Jackson,et al.  Variants of the melanocyte–stimulating hormone receptor gene are associated with red hair and fair skin in humans , 1995, Nature Genetics.

[43]  A. Marghoob,et al.  Practical Application of the New Classification Scheme for Congenital Melanocytic Nevi , 2015, Pediatric dermatology.

[44]  M. Reyes-Múgica,et al.  Neurocutaneous melanosis is associated with tethered spinal cord , 2014, Child's Nervous System.

[45]  D. Pinkel,et al.  Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. , 2007, The Journal of investigative dermatology.

[46]  D. Duffy,et al.  Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? , 2000, American journal of human genetics.